Shire PLC (SHP) Stock Rating Lowered by Barclays PLC
Other equities analysts have also recently issued reports about the stock. Goldman Sachs Group, Inc. (The) reaffirmed a buy rating and issued a GBX 6,800 ($88.28) price objective on shares of Shire PLC in a research note on Wednesday, May 3rd. Shore Capital reiterated a buy rating on shares of Shire PLC in a report on Monday, April 24th. Liberum Capital reiterated a buy rating and issued a GBX 5,500 ($71.40) target price on shares of Shire PLC in a report on Wednesday, May 3rd. Deutsche Bank AG reiterated a buy rating and issued a GBX 6,300 ($81.79) target price on shares of Shire PLC in a report on Wednesday, May 3rd. Finally, Jefferies Group LLC reiterated a buy rating and issued a GBX 6,400 ($83.08) target price on shares of Shire PLC in a report on Wednesday, May 3rd. Four research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of Buy and a consensus price target of GBX 5,907.88 ($76.70).
Shares of Shire PLC (SHP) opened at 3867.00 on Friday. The firm’s 50-day moving average is GBX 4,185.84 and its 200 day moving average is GBX 4,520.51. Shire PLC has a 52 week low of GBX 3,787.00 and a 52 week high of GBX 5,377.00. The firm’s market capitalization is GBX 35.05 billion.
COPYRIGHT VIOLATION NOTICE: “Shire PLC (SHP) Stock Rating Lowered by Barclays PLC” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/15/shire-plc-shp-stock-rating-lowered-by-barclays-plc.html.
The firm also recently declared a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be paid a GBX 3.85 ($0.05) dividend. The ex-dividend date is Thursday, September 7th. This represents a yield of 0.1%.
In other Shire PLC news, insider Dominic Blakemore purchased 152 shares of the stock in a transaction on Friday, June 30th. The shares were purchased at an average cost of GBX 4,255 ($55.24) per share, for a total transaction of £6,467.60 ($8,396.21).
About Shire PLC
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.